Scodix Announces Record-Breaking 2024: Achieves Profitability and 23% Revenue Growth, Driven by Groundbreaking Technology and Strategic Partnerships
ROSH HAAYIN, Israel, April 1, 2025 /PRNewswire/ -- Scodix SCDX the pioneer and global leader in digital embellishment, today announced its financial results and key milestones for the year ending December 31, 2024, marking a significant turning point in the company's history.
Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025
Autolus will host an R&D investor event on Wednesday, April 23, 2025 at 8:30am EDT.
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
Esteve Pharmaceuticals, S.A. will commercialize Increlex in all markets outside the U.S. Esteve Pharmaceuticals, S.A. will commercialize Increlex in all markets outside the U.S.
Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition - Tonix Pharmaceuticals ( NASDAQ:TNXP )
CHATHAM, N.J., April 01, 2025 ( GLOBE NEWSWIRE ) -- Tonix Pharmaceuticals Holding Corp. TNXP, a biopharmaceutical company with a portfolio of marketed products and a pipeline of development candidates, today announced the launch of TONIX ONE™, a fully-integrated digital platform designed to help ...
Apellis Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® ( pegcetacoplan ) for C3G and Primary IC-MPGN - Apellis Pharmaceuticals ( NASDAQ:APLS )
PDUFA target action date is July 28, 2025 WALTHAM, Mass., April 01, 2025 ( GLOBE NEWSWIRE ) -- Apellis Pharmaceuticals, Inc. APLS today announced that the U.S.
Rio Silver Pivots to High-Grade Silver Exploration / Exploitation - Announces Executive Changes - Rio Silver ( OTC:RYOOF )
VANCOUVER, British Columbia, April 01, 2025 ( GLOBE NEWSWIRE ) -- Rio Silver Inc. ( "Rio Silver" or the "Company" ) ( TSX.V: RYO ) RYOOF announces that it has appointed Eric H. Hinton, P.Eng., FCIM, to the Advisory Board. Eric H.
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
Company continues to progress toward the signing of a definitive merger agreement with Renovaro Company continues to progress toward the signing of a definitive merger agreement with ...
Renasant Corporation Completes Merger with The First Bancshares, Inc. - Renasant ( NYSE:RNST )
TUPELO, Miss., April 01, 2025 ( GLOBE NEWSWIRE ) -- Renasant Corporation RNST ( "Renasant" or "the Company" ) announced today that it has completed its merger with The First Bancshares, Inc., the parent company of The First Bank ( "The First" ) , effective April 1, 2025.
Apellis Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® ( pegcetacoplan ) for C3G and Primary IC-MPGN
WALTHAM, Mass., April 01, 2025 ( GLOBE NEWSWIRE ) -- Apellis Pharmaceuticals, Inc. ( Nasdaq: APLS ) today announced that the U.S. Food and Drug Administration ( FDA ) has accepted and granted Priority Review designation of the supplemental New Drug Application ( sNDA ) for EMPAVELI® ( ...
Sonoco Completes Sale of Thermoformed and Flexibles Packaging Business to TOPPAN Holdings, Inc. - Sonoco Prods ( NYSE:SON )
HARTSVILLE, S.C., April 01, 2025 ( GLOBE NEWSWIRE ) -- Sonoco Products Company ( "Sonoco" or the "Company" ) SON, a core mid-cap growth and value equity which is a global leader in high-value sustainable packaging, today announced it has completed the sale of its Thermoformed and Flexibles ...
